These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38639021)

  • 1. Paternal use of selective serotonin reuptake inhibitors and adverse health outcomes: A nationwide cohort study on 13,547 exposed children.
    Garvik OS; Jølving LR; Lund K; Friedman S; Nørgård BM
    Andrology; 2024 Apr; ():. PubMed ID: 38639021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-α Agents Before Conception.
    Larsen MD; Friedman S; Magnussen B; Nørgård BM
    Am J Gastroenterol; 2016 Nov; 111(11):1608-1613. PubMed ID: 27619836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reassuring results on birth outcomes in children fathered by men treated with azathioprine/6-mercaptopurine within 3 months before conception: a nationwide cohort study.
    Nørgård BM; Magnussen B; Larsen MD; Friedman S
    Gut; 2017 Oct; 66(10):1761-1766. PubMed ID: 27456154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Birth and Child Outcomes in Children Fathered by Men Treated with Antidiabetics Prior to Conception: A Nationwide Cohort Study.
    Nørgård BM; Fedder J; Jølving LR; Damkier P; Nielsen J
    J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paternal preconception exposure to non-steroid anti-inflammatory drugs or opioids and adverse birth outcomes: A nationwide registry-based cohort study.
    Lund K; Garvik OS; Aagaard SM; Jølving LR; Larsen MD; Damkier P; Nørgård BM
    Andrology; 2023 Nov; ():. PubMed ID: 37941509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Birth Outcome of Children Fathered by Men Treated with Systemic Corticosteroids during the Conception Period - A Cohort Study based on Nationwide Data.
    Larsen MD; Friedman S; Magnussen B; Nørgård BM
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):133-138. PubMed ID: 28804964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paternal country of origin and adverse neonatal outcomes in births to foreign-born women in Norway: A population-based cohort study.
    Vik ES; Aasheim V; Nilsen RM; Small R; Moster D; Schytt E
    PLoS Med; 2020 Nov; 17(11):e1003395. PubMed ID: 33147226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of autism spectrum disorder in offspring following paternal use of selective serotonin reuptake inhibitors before conception: a population-based cohort study.
    Yang F; Chen J; Miao MH; Yuan W; Li L; Liang H; Ehrenstein V; Li J
    BMJ Open; 2017 Dec; 7(12):e016368. PubMed ID: 29275337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse birth outcomes and early-life infections after in utero exposure to corticosteroids for inflammatory bowel disease: a Danish nationwide cohort study.
    Jølving LR; Nielsen J; Andersen ML; Friedman S; Nørgård BM
    BMC Med; 2023 Apr; 21(1):140. PubMed ID: 37046314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal Paternal Selective Serotonin Reuptake Inhibitors Use and Risk of ADHD in Offspring.
    Yang F; Liang H; Chen J; Miao M; Yuan W; Nørgaard M; Li J
    Pediatrics; 2018 Jan; 141(1):. PubMed ID: 29229680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study.
    Graner S; Svensson T; Beau AB; Damase-Michel C; Engeland A; Furu K; Hviid A; Håberg SE; Mølgaard-Nielsen D; Pasternak B; Kieler H
    BMJ; 2017 Feb; 356():j629. PubMed ID: 28246106
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
    Furu K; Kieler H; Haglund B; Engeland A; Selmer R; Stephansson O; Valdimarsdottir UA; Zoega H; Artama M; Gissler M; Malm H; Nørgaard M
    BMJ; 2015 Apr; 350():h1798. PubMed ID: 25888213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birth outcomes after preconception paternal exposure to methotrexate: A nationwide cohort study.
    Winter RW; Larsen MD; Magnussen B; Friedman S; Kammerlander H; Nørgård BM
    Reprod Toxicol; 2017 Dec; 74():219-223. PubMed ID: 29080667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
    Eke AC; Saccone G; Berghella V
    BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of paternal and maternal use of 5-aminosalicylic acid during conception and pregnancy: a nationwide cohort study.
    Nørgård BM; Friedman S; Kjeldsen J; Nielsen J
    Aliment Pharmacol Ther; 2022 Nov; 56(9):1349-1360. PubMed ID: 36031741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data.
    Malm H; Sourander A; Gissler M; Gyllenberg D; Hinkka-Yli-Salomäki S; McKeague IW; Artama M; Brown AS
    Am J Psychiatry; 2015 Dec; 172(12):1224-32. PubMed ID: 26238606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
    Grzeskowiak LE; Gilbert AL; Morrison JL
    J Clin Psychopharmacol; 2012 Oct; 32(5):615-21. PubMed ID: 22926594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of adverse birth outcomes after maternal varenicline use: A population-based observational study in Denmark and Sweden.
    Pedersen L; Petronis KR; Nørgaard M; Mo J; Frøslev T; Stephansson O; Granath F; Kieler H; Sørensen HT
    Pharmacoepidemiol Drug Saf; 2020 Jan; 29(1):94-102. PubMed ID: 31713302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of selective serotonin reuptake inhibitor use and risk for preterm birth and related adverse events: with a consideration of the COVID-19 pandemic period.
    Hwang YM; Roper RT; Piekos SN; Enquobahrie DA; Hebert MF; Paquette AG; Baloni P; Price ND; Hood L; Hadlock JJ
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2313364. PubMed ID: 38342572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.